Recent legislation has provided a faster path to market for biologics which are positioned to revolutionize the field of protein therapeutics. HRA®
coupled clinical, regulatory, and survey information with the economics of biosimilars to improve understanding and critical thinking in the field. HRA®
conducted an online survey with 160 Rheumatologists and Oncologists designed to yield insights into potential drivers of biosimilar prescribing.
This webinar can help you answer questions, such as:
- Is there really a potential for cost-saving with biosimilars?
- Will this be a competitive space?
- What are physician attitudes towards biosimilars versus biologics?
- What are the key drivers of physician’s uptake of biosimilars?
- When will physicians be confident in biosimilars?
- Gain knowledge of the competitive landscape today and what it could be tomorrow
- Position your biosimilar for success
- Craft successful physician messaging for your marketing campaigns
- Use this research to jumpstart on your competitive intelligence business objectives